Genetic validation of β-secretase as a drug target for Alzheimer's Disease

被引：0
|
作者：
MacDonald, M [1 ]
机构：
[1] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada
来源：
CLINICAL GENETICS | 2004年 / 65卷 / 06期
关键词：
D O I：
10.1111/j.1399-0004.2004.00257c.x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
下载
收藏
页码：459 / 460
页数：2
相关论文
共 50 条
  • [21] Beta-secretase inhibition as a therapeutic target for Alzheimer's disease
    Tang, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S3 - S3
  • [22] Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention
    Rynearson, Kevin D.
    Ponnusamy, Moorthi
    Prikhodko, Olga
    Xie, Yuhuan
    Zhang, Can
    Nguyen, Phuong
    Hug, Brenda
    Sawa, Mariko
    Becker, Ann
    Spencer, Brian
    Florio, Jazmin
    Mante, Michael
    Salehi, Bahar
    Arias, Carlos
    Galasko, Douglas
    Head, Brian P.
    Johnson, Graham
    Lin, Jiunn H.
    Duddy, Steven K.
    Rissman, Robert A.
    Mobley, William C.
    Thinakaran, Gopal
    Tanzi, Rudolph E.
    Wagner, Steven L.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (04):
  • [23] Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors
    Francesca Mancini
    Angela De Simone
    Vincenza Andrisano
    Analytical and Bioanalytical Chemistry, 2011, 400 : 1979 - 1996
  • [24] Stabilized proteolipobead microenvironments for the functional analysis and drug screening of the cancer and Alzheimer's disease drug target gamma-secretase
    Gilchrist, Lane
    Martin, Jesse
    Hur, Ji Yuen
    Li, Yueming
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [25] β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease
    Menting, Kelly Willemijn
    Claassen, Jurgen A. H. R.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6 : 1 - 20
  • [26] Tau as a drug target in Alzheimer's disease
    Gozes, I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (03) : 337 - 338
  • [27] Tau as a drug target in Alzheimer’s disease
    Illana Gozes
    Journal of Molecular Neuroscience, 2002, 19 : 337 - 338
  • [28] ACAT as a drug target for Alzheimer's disease
    Huttunen, Henri J.
    Kovacs, Dora M.
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 212 - 214
  • [29] Spherons as a drug target in Alzheimer's disease
    Averback, P
    DRUG NEWS & PERSPECTIVES, 1998, 11 (08) : 469 - 479
  • [30] A novel drug target in Alzheimer's disease
    Bornebroek, M
    Kumar-Singh, S
    LANCET, 2004, 364 (9447): : 1738 - 1739
12345